financetom
Business
financetom
/
Business
/
Willis Towers Watson Strikes Co-Brokerage Agreement With The J. Morey Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Willis Towers Watson Strikes Co-Brokerage Agreement With The J. Morey Company
Oct 2, 2024 11:16 AM

01:55 PM EDT, 10/02/2024 (MT Newswires) -- Willis Towers Watson ( WTW ) said Wednesday it has struck a co-brokerage arrangement with The J. Morey Company, an Ori-gen family company.

The agreement will align resources to deliver brokerage support and insurance solutions to North American exposures of companies with headquarters in Japan, the company said.

Price: 296.76, Change: -3.82, Percent Change: -1.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Stonepeak To Acquire Forgital Group From Carlyle
BRIEF-Stonepeak To Acquire Forgital Group From Carlyle
Dec 16, 2024
Dec 16 (Reuters) - Carlyle Group Inc ( CG ): * STONEPEAK TO ACQUIRE FORGITAL GROUP FROM CARLYLE Source text: Further company coverage: ...
BRIEF-Healwell To Acquire Orion Health, And Launches $50 Million Bought Deal Financing
BRIEF-Healwell To Acquire Orion Health, And Launches $50 Million Bought Deal Financing
Dec 16, 2024
Dec 16 (Reuters) - Healwell Al Inc ( HWAIF ): * HEALWELL TO ACQUIRE ORION HEALTH, CREATING A GLOBAL MARKET LEADER IN HEALTHCARE DATA INTEROPERABILITY & ARTIFICIAL INTELLIGENCE, AND LAUNCHES $50 MILLION BOUGHT DEAL FINANCING * TO PAY $144M CAD UPFRONT FOR ORION HEALTH Source text: Further company coverage: ...
Innoviva to Sell Basilea Pharmaceutica's MRSA Antibiotic Zevtera in US Under Exclusive Deal
Innoviva to Sell Basilea Pharmaceutica's MRSA Antibiotic Zevtera in US Under Exclusive Deal
Dec 16, 2024
08:40 AM EST, 12/16/2024 (MT Newswires) -- Innoviva ( INVA ) unit Innoviva Specialty Therapeutics said Monday it signed an exclusive licensing and distribution deal with Basilea Pharmaceutica for US marketing rights to the antibiotic Zevtera or ceftobiprole. The company, which plans to launch Zevtera in the US by mid-2025, said it will pay Basilea $4 million upfront, with additional...
Municipal Bond Offerings This Week Record High Flood Scores
Municipal Bond Offerings This Week Record High Flood Scores
Dec 16, 2024
08:40 AM EST, 12/16/2024 (MT Newswires) -- Multiple municipal bond offerings this week have a high exposure to climate risk, specifically high Flood Scores, according to ICE Climate Data. A $1 million offering from Frankfort, N.Y., records a Flood Score of 3.9 out of 5.0, ICE reports. Locations with a component Physical Climate Risk Score, which includes Flood, Wildfire and...
Copyright 2023-2025 - www.financetom.com All Rights Reserved